Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial | Zendy

Fernando Bril | Zendy; Paola Portillo Sánchez | Zendy; Romina Lomonaco | Zendy; Beverly Orsak | Zendy; Joan Hecht | Zendy; Fermin O. Tio | Zendy; Kenneth Cusi | Zendy

Open Access

Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial

Author(s) -

Fernando Bril,

Paola Portillo Sánchez,

Romina Lomonaco,

Beverly Orsak,

Joan Hecht,

Fermin O. Tio,

Kenneth Cusi

Publication year - 2017

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2017-00867

Subject(s) - nonalcoholic steatohepatitis , prediabetes , post hoc analysis , medicine , randomized controlled trial , steatohepatitis , post hoc , gastroenterology , nonalcoholic fatty liver disease , fatty liver , type 2 diabetes , endocrinology , diabetes mellitus , disease

Patients with nonalcoholic fatty liver disease have a high cardiovascular risk, but statins are rarely prescribed because of fear of hepatotoxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research